Stay updated on Naptumomab + Durvalumab in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Naptumomab + Durvalumab in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Naptumomab + Durvalumab in Solid Tumors Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The site footer now identifies the ClinicalTrials.gov release as v3.8.0 instead of v3.7.2.
    Difference
    0.1%
    Check dated 2026-11-02T13:34:29.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    A banner announces NIH’s terminology transition, stating that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” and linking to updates and FAQs.
    Difference
    0.6%
    Check dated 2026-10-26T13:56:54.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The website’s footer revision label changes from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-19T13:55:14.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The footer site revision identifier changes from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-12T14:50:51.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    An updated revision entry labeled v3.7.0 was added to the record history, replacing the previous v3.6.6 and indicating the page was updated.
    Difference
    0.1%
    Check dated 2026-09-21T19:58:43.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    The page history shows a new revision tag, updating from v3.6.5 to v3.6.6. This signals a new version of the record metadata rather than changes to the study details.
    Difference
    0.1%
    Check dated 2026-08-31T17:33:06.000Z thumbnail image

Stay in the know with updates to Naptumomab + Durvalumab in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Naptumomab + Durvalumab in Solid Tumors Clinical Trial page.